Quetiapine

🧮 Dose calculator

Schizophrenia · Regimen source: FDA Quetiapine · 2.2, Table 1

• • Day 1: 50, day 2: 100, day 3: 200, day 4: 300, day 5: 400 mg/day in two doses; then ≤100 mg/day steps within 400–800. FDA Quetiapine · 2.2, Table 1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Quetiapine · 8.1

  “… ychotics at 1-866-961-2388 or online at http://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/ Risk Summary Neonates exposed to antipsychotic drugs (including quetiapine tablet) during the third trimester are at risk for extrapyramidal and/or withdrawal symptoms following delivery (see …”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Quetiapine · 8.2

  “Risk Summary Limited data from published literature report the presence of quetiapine in human breast milk at relative infant dose of <1% of the maternal weight-adjusted dosage.”

• 👶 ChildrenDangerous / avoid

  Boxed warning in the label about children. FDA Quetiapine · Boxed Warning

  “Quetiapine is not approved for use in pediatric patients under ten years of age [ see Use in Specific Populations (8.4) ].”

• 👴 Older adultsDangerous / avoid

  Label: serious warning or avoid in older adults. FDA Quetiapine · Boxed Warning

  “Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death [ see Warnings and Precautions (5.1) ].”

• ⚥ Females & males of reproductive potentialUse with caution

  Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Quetiapine · 8.3

  “Infertility Females Based on the pharmacologic action of quetiapine (D2 antagonism), treatment with quetiapine tablets may result in an increase in serum prolactin levels, which may lead to a reversible reduction in fertility in females of reproductive potential [see Warnings and Precautions ( 5.15 )].”